1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Skin Neoplasm: new trials by email Literature Review of Skin Neoplasm trials Research Report on Skin Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients 131I-Tenatumomab - Breast Neoplasm, Head and Neck Neoplasm | Phase 1 | Terminated | sigma-tau i.f.r. S.p.A. | 2 | 2015-11-01 | 2018-09-18 |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma ASN-002, 5-FU - Basal Cell Nevus Syndrome, Skin Neoplasm | Phase 1 / Phase 2 | Completed | Ascend Biopharmaceuticals Ltd | 16 | 2015-09-01 | 2018-06-06 |
Skin Neoplasms (2) · Basal Cell Nevus Syndrome (1) · Breast Neoplasms (1) · Digestive System Neoplasms (1) · Head and Neck Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms, Connective and Soft Tissue (1) · Pancreatic Neoplasms (1) · Respiratory Tract Neoplasms (1) · Urogenital Neoplasms (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Abnormalities, Multiple (1) · Bone Cysts (1) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Breast Diseases (1) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cysts (1)
Fluorouracil (1) · gusacitinib (1)
Ascend Biopharmaceuticals Ltd (1) · sigma-tau i.f.r. S.p.A. (1)
Australia (1) · France (1) · Italy (1)
Gregory Siller (1) · Lynda Spelman (1) · Rodney Sinclair (1)
2014 (1)